A short interval between bevacizumab and anti-epithelial growth factor receptor therapy interferes with efficacy of subsequent anti-EGFR therapy for refractory colorectal cancer
Taniguchi, Hiroya, Komori, Azusa, Narita, Yukiya, Kadowaki, Shigenori, Ura, Takashi, Andoh, Masashi, Yatabe, Yasushi, Komori, Koji, Kimura, Kenichi, Kinoshita, Takashi, Muro, KeiLanguage:
english
Journal:
Japanese Journal of Clinical Oncology
DOI:
10.1093/jjco/hyv193
Date:
January, 2016
File:
PDF, 276 KB
english, 2016